AMARYL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey.

Active ingredients

The drug AMARYL contains one active pharmaceutical ingredient (API):

1	Glimepiride UNII 6KY687524K - GLIMEPIRIDE
	Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
	Read more about Glimepiride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AMARYL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB12	Glimepiride	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8450R, 8451T, 8452W, 8533D
BR	Câmara de Regulação do Mercado de Medicamentos	502800603115314, 576720060073617, 576720060073717, 576720060073817, 576720060073917, 576720060074017, 576720060074117, 576720060074217, 576720060074317
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00367752, 00782675, 02751845, 03215310, 03500430, 03897522, 04102565, 04711459, 04748899, 09262196, 09262204, 09262233, 09262256, 09262345, 09262351, 09262374, 09262397, 09284513
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.503-07-05, 26.504-07-05
EE	Ravimiamet	1084957, 1084968, 1084979, 1084980, 1110328, 1110339, 1125391, 1125403, 1395121, 1395132, 1429523, 1429534, 1429545, 1429556, 1429567, 1429578, 1429589, 1429590, 1429602, 1429613, 1429624, 1429635, 1429646, 1429657, 1429668, 1429679, 1429680, 1429691, 1429703, 1429714, 1429725, 1429736, 1429747, 1429758, 1429769, 1429770, 1429781, 1429792, 1429804, 1429815, 1429826, 1429837, 1429848, 1429859, 1429860, 1429871, 1429882, 1429893, 1429905, 1429916, 1433270, 1542765, 1542787, 1542798, 1542800, 1542811, 1670981, 1670992, 1671016, 1671027, 1671038, 1671049, 1671050, 1671061, 1671072, 1671083, 1671117, 1671128, 1671139, 1671140, 1671151, 1671162, 1671173, 1671184, 1671195, 1671207, 1846942, 1846997, 1847011, 1847033, 1847044, 1847055, 1847066, 1847077, 1847088, 1848405
ES	Centro de información online de medicamentos de la AEMPS	61406, 61409
FI	Lääkealan turvallisuus- ja kehittämiskeskus	004586, 091751, 091769, 097881
HK	Department of Health Drug Office	42323, 42325
HR	Agencija za lijekove i medicinske proizvode	HR-H-836629436, HR-H-851734879
IE	Health Products Regulatory Authority	12576, 12706, 12713, 12738, 12916
IL	מִשְׂרַד הַבְּרִיאוּת	4390, 4391, 4392, 6385
IT	Agenzia del Farmaco	032845012, 032845164, 032845226
JP	医薬品医療機器総合機構	3961008F1020, 3961008F2027, 3961008F3023
LT	Valstybinė vaistų kontrolės tarnyba	1003243, 1003748, 1003774, 1003775, 1050505, 1050506, 1050507, 1050508, 1050509, 1050510, 1050511, 1050512, 1050513, 1050514, 1050515, 1050516, 1050517, 1050518, 1050519, 1050520, 1050521, 1050522, 1050523, 1050524, 1050525, 1050526, 1050527, 1050528, 1050529, 1050530, 1050531, 1050532, 1050533, 1050534, 1050535, 1050536, 1050537, 1050538, 1050539, 1050540, 1052221, 1063343, 1063344, 1063345, 1063346, 1066052, 1072788, 1072789, 1072790, 1075583, 1075584, 1081253, 1081254
MT	Medicines Authority	AA1438/00501, AA1438/00502, AA1438/00503, AA1438/00504, AA908/09809, AA908/09810, AA908/09811, AA908/09812
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	466M97
NG	Registered Drug Product Database	04-2853, 04-2854, A4-3074
Switch country to Nigeria in order to find specific presentations of AMARYL
NL	Z-Index G-Standaard, PRK	44423, 44431, 44458, 44466
PL	Rejestru Produktów Leczniczych	100078329, 100078335, 100078341, 100078358, 100240681, 100464083
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62433001, W62433002, W62433003, W62433004, W62433005, W62433006, W62433007, W62433008, W62433009, W62433010, W62433011, W62433012, W62434001, W62434002, W62434003, W62434004, W62434005, W62434006, W62434007, W62434008, W62434009, W62434010, W62434011, W62435001, W62435002, W62435003, W62435004, W62435005, W62435006, W62435007, W62435008, W62435009, W62435010, W62435011, W62436001, W62436002, W62436003, W62436004, W62436005, W62436006, W62436007, W62436008, W62436009, W62436010, W62436011, W62437001, W62437002, W62437003, W62437004, W62437005, W62437006, W62437007, W62437008, W62437009, W62437010, W62437011
SG	Health Sciences Authority	10459P, 10460P, 10462P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809010208, 8699809010215, 8699809010222, 8699809010239, 8699809018358, 8699809018372
US	FDA, National Drug Code	0039-0221, 0039-0222, 0039-0223
ZA	Health Products Regulatory Authority	30/21.2/0060, 30/21.2/0061, 30/21.2/0063